A PHP Error was encountered

Severity: Warning

Message: fopen(/var/cpanel/php/sessions/ea-php72/ci_sessiona889d6f4244e30c14eceb28ed283ab652ea6afc1): failed to open stream: No space left on device

Filename: drivers/Session_files_driver.php

Line Number: 176

Backtrace:

File: /home/rejovjcx/mraccuracyreports.com/application/controllers/Reportdetails.php
Line: 10
Function: library

File: /home/rejovjcx/mraccuracyreports.com/index.php
Line: 315
Function: require_once

A PHP Error was encountered

Severity: Warning

Message: session_start(): Failed to read session data: user (path: /var/cpanel/php/sessions/ea-php72)

Filename: Session/Session.php

Line Number: 143

Backtrace:

File: /home/rejovjcx/mraccuracyreports.com/application/controllers/Reportdetails.php
Line: 10
Function: library

File: /home/rejovjcx/mraccuracyreports.com/index.php
Line: 315
Function: require_once

Global Sexually Transmitted Diseases (STD) Testing Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application

img

Global Sexually Transmitted Diseases (STD) Testing Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Sexually Transmitted Diseases (STD) Testing Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application

Sexually Transmitted Diseases (STD) Testing is used to detect all kinds of Sexually Transmitted virus.Sexually transmitted diseases are considered as one of the most critical health challenges globally. Chlamydia, gonorrhea, and herpes simplex virus are some of the highly prevalent sexually transmitted diseases.
Global Sexually Transmitted Diseases (STD) Testing market is projected to reach US$ 100680 million in 2033, increasing from US$ 78450 million in 2022, with the CAGR of 3.2% during the period of 2023 to 2033. Demand from Laboratory Testing and Point of Care (POC) Testing are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Sexually Transmitted Diseases (STD) Testing industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033.
Globally, Sexually Transmitted Diseases (STD) Testing key companies include ROCHE HOLDINGS, BIOMERIEUX, HOLOGIC, BECTON DICKINSON, ORASURE, DANAHER, AFFYMETRIX, ABBOTT LABORATORIES and BIO-RAD LABORATORIES, etc. ROCHE HOLDINGS, BIOMERIEUX, HOLOGIC are top 3 players and held % share in total in 2022.
Sexually Transmitted Diseases (STD) Testing can be divided into Chlamydia, Syphilis, Gonorrhea and Herpes Simplex Virus, etc. Chlamydia is the mainstream product in the market, accounting for % share globally in 2022.
Sexually Transmitted Diseases (STD) Testing is widely used in various fields, such as Laboratory Testing and Point of Care (POC) Testing, etc. Laboratory Testing provides greatest supports to the Sexually Transmitted Diseases (STD) Testing industry development. In 2022, global % share of Sexually Transmitted Diseases (STD) Testing went into Laboratory Testing filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Sexually Transmitted Diseases (STD) Testing market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report



By Company


ROCHE HOLDINGS
BIOMERIEUX
HOLOGIC
BECTON DICKINSON
ORASURE
DANAHER
AFFYMETRIX
ABBOTT LABORATORIES
BIO-RAD LABORATORIES
DIASORIN
Segment by Type
Chlamydia
Syphilis
Gonorrhea
Herpes Simplex Virus
Human Papilloma Virus
Human Immunodeficiency Virus
Others

Segment by Application


Laboratory Testing
Point of Care (POC) Testing
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries

Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia

Latin America
Mexico
Brazil

Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Sexually Transmitted Diseases (STD) Testing market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2033).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Sexually Transmitted Diseases (STD) Testing introduction, etc. Sexually Transmitted Diseases (STD) Testing Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12MRAResearch’s Conclusions of Sexually Transmitted Diseases (STD) Testing market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by MRAResearch.

Table of Content

1 Market Overview of Sexually Transmitted Diseases (STD) Testing
1.1 Sexually Transmitted Diseases (STD) Testing Market Overview
1.1.1 Sexually Transmitted Diseases (STD) Testing Product Scope
1.1.2 Sexually Transmitted Diseases (STD) Testing Market Status and Outlook
1.2 Global Sexually Transmitted Diseases (STD) Testing Market Size Overview by Region 2018 VS 2022 VS 2033
1.3 Global Sexually Transmitted Diseases (STD) Testing Market Size by Region (2018-2033)
1.4 Global Sexually Transmitted Diseases (STD) Testing Historic Market Size by Region (2018-2023)
1.5 Global Sexually Transmitted Diseases (STD) Testing Market Size Forecast by Region (2024-2033)
1.6 Key Regions, Sexually Transmitted Diseases (STD) Testing Market Size (2018-2033)
1.6.1 North America Sexually Transmitted Diseases (STD) Testing Market Size (2018-2033)
1.6.2 Europe Sexually Transmitted Diseases (STD) Testing Market Size (2018-2033)
1.6.3 Asia-Pacific Sexually Transmitted Diseases (STD) Testing Market Size (2018-2033)
1.6.4 Latin America Sexually Transmitted Diseases (STD) Testing Market Size (2018-2033)
1.6.5 Middle East & Africa Sexually Transmitted Diseases (STD) Testing Market Size (2018-2033)
2 Sexually Transmitted Diseases (STD) Testing Market by Type
2.1 Introduction
2.1.1 Chlamydia
2.1.2 Syphilis
2.1.3 Gonorrhea
2.1.4 Herpes Simplex Virus
2.1.5 Human Papilloma Virus
2.1.6 Human Immunodeficiency Virus
2.1.7 Others
2.2 Global Sexually Transmitted Diseases (STD) Testing Market Size by Type: 2018 VS 2022 VS 2033
2.2.1 Global Sexually Transmitted Diseases (STD) Testing Historic Market Size by Type (2018-2023)
2.2.2 Global Sexually Transmitted Diseases (STD) Testing Forecasted Market Size by Type (2024-2033)
2.3 Key Regions Market Size by Type
2.3.1 North America Sexually Transmitted Diseases (STD) Testing Revenue Breakdown by Type (2018-2033)
2.3.2 Europe Sexually Transmitted Diseases (STD) Testing Revenue Breakdown by Type (2018-2033)
2.3.3 Asia-Pacific Sexually Transmitted Diseases (STD) Testing Revenue Breakdown by Type (2018-2033)
2.3.4 Latin America Sexually Transmitted Diseases (STD) Testing Revenue Breakdown by Type (2018-2033)
2.3.5 Middle East and Africa Sexually Transmitted Diseases (STD) Testing Revenue Breakdown by Type (2018-2033)
3 Sexually Transmitted Diseases (STD) Testing Market Overview by Application
3.1 Introduction
3.1.1 Laboratory Testing
3.1.2 Point of Care (POC) Testing
3.2 Global Sexually Transmitted Diseases (STD) Testing Market Size by Application: 2018 VS 2022 VS 2033
3.2.1 Global Sexually Transmitted Diseases (STD) Testing Historic Market Size by Application (2018-2023)
3.2.2 Global Sexually Transmitted Diseases (STD) Testing Forecasted Market Size by Application (2024-2033)
3.3 Key Regions Market Size by Application
3.3.1 North America Sexually Transmitted Diseases (STD) Testing Revenue Breakdown by Application (2018-2033)
3.3.2 Europe Sexually Transmitted Diseases (STD) Testing Revenue Breakdown by Application (2018-2033)
3.3.3 Asia-Pacific Sexually Transmitted Diseases (STD) Testing Revenue Breakdown by Application (2018-2033)
3.3.4 Latin America Sexually Transmitted Diseases (STD) Testing Revenue Breakdown by Application (2018-2033)
3.3.5 Middle East and Africa Sexually Transmitted Diseases (STD) Testing Revenue Breakdown by Application (2018-2033)
4 Sexually Transmitted Diseases (STD) Testing Competition Analysis by Players
4.1 Global Sexually Transmitted Diseases (STD) Testing Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Sexually Transmitted Diseases (STD) Testing as of 2022)
4.3 Date of Key Players Enter into Sexually Transmitted Diseases (STD) Testing Market
4.4 Global Top Players Sexually Transmitted Diseases (STD) Testing Headquarters and Area Served
4.5 Key Players Sexually Transmitted Diseases (STD) Testing Product Solution and Service
4.6 Competitive Status
4.6.1 Sexually Transmitted Diseases (STD) Testing Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 ROCHE HOLDINGS
5.1.1 ROCHE HOLDINGS Profile
5.1.2 ROCHE HOLDINGS Main Business
5.1.3 ROCHE HOLDINGS Sexually Transmitted Diseases (STD) Testing Products, Services and Solutions
5.1.4 ROCHE HOLDINGS Sexually Transmitted Diseases (STD) Testing Revenue (US$ Million) & (2018-2023)
5.1.5 ROCHE HOLDINGS Recent Developments
5.2 BIOMERIEUX
5.2.1 BIOMERIEUX Profile
5.2.2 BIOMERIEUX Main Business
5.2.3 BIOMERIEUX Sexually Transmitted Diseases (STD) Testing Products, Services and Solutions
5.2.4 BIOMERIEUX Sexually Transmitted Diseases (STD) Testing Revenue (US$ Million) & (2018-2023)
5.2.5 BIOMERIEUX Recent Developments
5.3 HOLOGIC
5.3.1 HOLOGIC Profile
5.3.2 HOLOGIC Main Business
5.3.3 HOLOGIC Sexually Transmitted Diseases (STD) Testing Products, Services and Solutions
5.3.4 HOLOGIC Sexually Transmitted Diseases (STD) Testing Revenue (US$ Million) & (2018-2023)
5.3.5 BECTON DICKINSON Recent Developments
5.4 BECTON DICKINSON
5.4.1 BECTON DICKINSON Profile
5.4.2 BECTON DICKINSON Main Business
5.4.3 BECTON DICKINSON Sexually Transmitted Diseases (STD) Testing Products, Services and Solutions
5.4.4 BECTON DICKINSON Sexually Transmitted Diseases (STD) Testing Revenue (US$ Million) & (2018-2023)
5.4.5 BECTON DICKINSON Recent Developments
5.5 ORASURE
5.5.1 ORASURE Profile
5.5.2 ORASURE Main Business
5.5.3 ORASURE Sexually Transmitted Diseases (STD) Testing Products, Services and Solutions
5.5.4 ORASURE Sexually Transmitted Diseases (STD) Testing Revenue (US$ Million) & (2018-2023)
5.5.5 ORASURE Recent Developments
5.6 DANAHER
5.6.1 DANAHER Profile
5.6.2 DANAHER Main Business
5.6.3 DANAHER Sexually Transmitted Diseases (STD) Testing Products, Services and Solutions
5.6.4 DANAHER Sexually Transmitted Diseases (STD) Testing Revenue (US$ Million) & (2018-2023)
5.6.5 DANAHER Recent Developments
5.7 AFFYMETRIX
5.7.1 AFFYMETRIX Profile
5.7.2 AFFYMETRIX Main Business
5.7.3 AFFYMETRIX Sexually Transmitted Diseases (STD) Testing Products, Services and Solutions
5.7.4 AFFYMETRIX Sexually Transmitted Diseases (STD) Testing Revenue (US$ Million) & (2018-2023)
5.7.5 AFFYMETRIX Recent Developments
5.8 ABBOTT LABORATORIES
5.8.1 ABBOTT LABORATORIES Profile
5.8.2 ABBOTT LABORATORIES Main Business
5.8.3 ABBOTT LABORATORIES Sexually Transmitted Diseases (STD) Testing Products, Services and Solutions
5.8.4 ABBOTT LABORATORIES Sexually Transmitted Diseases (STD) Testing Revenue (US$ Million) & (2018-2023)
5.8.5 ABBOTT LABORATORIES Recent Developments
5.9 BIO-RAD LABORATORIES
5.9.1 BIO-RAD LABORATORIES Profile
5.9.2 BIO-RAD LABORATORIES Main Business
5.9.3 BIO-RAD LABORATORIES Sexually Transmitted Diseases (STD) Testing Products, Services and Solutions
5.9.4 BIO-RAD LABORATORIES Sexually Transmitted Diseases (STD) Testing Revenue (US$ Million) & (2018-2023)
5.9.5 BIO-RAD LABORATORIES Recent Developments
5.10 DIASORIN
5.10.1 DIASORIN Profile
5.10.2 DIASORIN Main Business
5.10.3 DIASORIN Sexually Transmitted Diseases (STD) Testing Products, Services and Solutions
5.10.4 DIASORIN Sexually Transmitted Diseases (STD) Testing Revenue (US$ Million) & (2018-2023)
5.10.5 DIASORIN Recent Developments
6 North America
6.1 North America Sexually Transmitted Diseases (STD) Testing Market Size by Country (2018-2033)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Sexually Transmitted Diseases (STD) Testing Market Size by Country (2018-2033)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Sexually Transmitted Diseases (STD) Testing Market Size by Region (2018-2033)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Sexually Transmitted Diseases (STD) Testing Market Size by Country (2018-2033)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Sexually Transmitted Diseases (STD) Testing Market Size by Country (2018-2033)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Sexually Transmitted Diseases (STD) Testing Market Dynamics
11.1 Sexually Transmitted Diseases (STD) Testing Industry Trends
11.2 Sexually Transmitted Diseases (STD) Testing Market Drivers
11.3 Sexually Transmitted Diseases (STD) Testing Market Challenges
11.4 Sexually Transmitted Diseases (STD) Testing Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Figure

List of Tables
Table 1. Global Market Sexually Transmitted Diseases (STD) Testing Market Size (US$ Million) Comparison by Region 2018 VS 2022 VS 2033
Table 2. Global Sexually Transmitted Diseases (STD) Testing Market Size by Region (2018-2023) & (US$ Million)
Table 3. Global Sexually Transmitted Diseases (STD) Testing Market Size Share by Region (2018-2023)
Table 4. Global Sexually Transmitted Diseases (STD) Testing Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 5. Global Sexually Transmitted Diseases (STD) Testing Forecasted Market Size Share by Region (2024-2033)
Table 6. Global Sexually Transmitted Diseases (STD) Testing Market Size (US$ Million) by Type: 2018 VS 2022 VS 2033
Table 7. Global Sexually Transmitted Diseases (STD) Testing Market Size by Type (2018-2023) & (US$ Million)
Table 8. Global Sexually Transmitted Diseases (STD) Testing Revenue Market Share by Type (2018-2023)
Table 9. Global Sexually Transmitted Diseases (STD) Testing Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 10. Global Sexually Transmitted Diseases (STD) Testing Revenue Market Share by Type (2024-2033)
Table 11. North America Sexually Transmitted Diseases (STD) Testing Revenue by Type (2018-2023) & (US$ Million)
Table 12. North America Sexually Transmitted Diseases (STD) Testing Revenue by Type (2024-2033) & (US$ Million)
Table 13. Europe Sexually Transmitted Diseases (STD) Testing Revenue by Type (2018-2023) & (US$ Million)
Table 14. Europe Sexually Transmitted Diseases (STD) Testing Revenue by Type (2024-2033) & (US$ Million)
Table 15. Asia-Pacific Sexually Transmitted Diseases (STD) Testing Revenue by Type (2018-2023) & (US$ Million)
Table 16. Asia-Pacific Sexually Transmitted Diseases (STD) Testing Revenue by Type (2024-2033) & (US$ Million)
Table 17. Latin America Sexually Transmitted Diseases (STD) Testing Revenue by Type (2018-2023) & (US$ Million)
Table 18. Latin America Sexually Transmitted Diseases (STD) Testing Revenue by Type (2024-2033) & (US$ Million)
Table 19. Middle East and Africa Sexually Transmitted Diseases (STD) Testing Revenue by Type (2018-2023) & (US$ Million)
Table 20. Middle East and Africa Sexually Transmitted Diseases (STD) Testing Revenue by Type (2024-2033) & (US$ Million)
Table 21. Global Sexually Transmitted Diseases (STD) Testing Market Size (US$ Million) by Application: 2018 VS 2022 VS 2033
Table 22. Global Sexually Transmitted Diseases (STD) Testing Market Size by Application (2018-2023) & (US$ Million)
Table 23. Global Sexually Transmitted Diseases (STD) Testing Revenue Market Share by Application (2018-2023)
Table 24. Global Sexually Transmitted Diseases (STD) Testing Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 25. Global Sexually Transmitted Diseases (STD) Testing Revenue Market Share by Application (2024-2033)
Table 26. North America Sexually Transmitted Diseases (STD) Testing Revenue by Application (2018-2023) & (US$ Million)
Table 27. North America Sexually Transmitted Diseases (STD) Testing Revenue by Application (2024-2033) & (US$ Million)
Table 28. Europe Sexually Transmitted Diseases (STD) Testing Revenue by Application (2018-2023) & (US$ Million)
Table 29. Europe Sexually Transmitted Diseases (STD) Testing Revenue by Application (2024-2033) & (US$ Million)
Table 30. Asia-Pacific Sexually Transmitted Diseases (STD) Testing Revenue by Application (2018-2023) & (US$ Million)
Table 31. Asia-Pacific Sexually Transmitted Diseases (STD) Testing Revenue by Application (2024-2033) & (US$ Million)
Table 32. Latin America Sexually Transmitted Diseases (STD) Testing Revenue by Application (2018-2023) & (US$ Million)
Table 33. Latin America Sexually Transmitted Diseases (STD) Testing Revenue by Application (2024-2033) & (US$ Million)
Table 34. Middle East and Africa Sexually Transmitted Diseases (STD) Testing Revenue by Application (2018-2023) & (US$ Million)
Table 35. Middle East and Africa Sexually Transmitted Diseases (STD) Testing Revenue by Application (2024-2033) & (US$ Million)
Table 36. Global Sexually Transmitted Diseases (STD) Testing Revenue (US$ Million) by Players (2018-2023)
Table 37. Global Sexually Transmitted Diseases (STD) Testing Revenue Market Share by Players (2018-2023)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Sexually Transmitted Diseases (STD) Testing as of 2022)
Table 39. Date of Key Players Enter into Sexually Transmitted Diseases (STD) Testing Market
Table 40. Global Sexually Transmitted Diseases (STD) Testing Key Players Headquarters and Area Served
Table 41. Sexually Transmitted Diseases (STD) Testing Product Solution and Service
Table 42. Global Sexually Transmitted Diseases (STD) Testing Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. ROCHE HOLDINGS Basic Information List
Table 45. ROCHE HOLDINGS Description and Business Overview
Table 46. ROCHE HOLDINGS Sexually Transmitted Diseases (STD) Testing Products, Services and Solutions
Table 47. Revenue (US$ Million) in Sexually Transmitted Diseases (STD) Testing Business of ROCHE HOLDINGS (2018-2023)
Table 48. ROCHE HOLDINGS Recent Developments
Table 49. BIOMERIEUX Basic Information List
Table 50. BIOMERIEUX Description and Business Overview
Table 51. BIOMERIEUX Sexually Transmitted Diseases (STD) Testing Products, Services and Solutions
Table 52. Revenue (US$ Million) in Sexually Transmitted Diseases (STD) Testing Business of BIOMERIEUX (2018-2023)
Table 53. BIOMERIEUX Recent Developments
Table 54. HOLOGIC Basic Information List
Table 55. HOLOGIC Description and Business Overview
Table 56. HOLOGIC Sexually Transmitted Diseases (STD) Testing Products, Services and Solutions
Table 57. Revenue (US$ Million) in Sexually Transmitted Diseases (STD) Testing Business of HOLOGIC (2018-2023)
Table 58. HOLOGIC Recent Developments
Table 59. BECTON DICKINSON Basic Information List
Table 60. BECTON DICKINSON Description and Business Overview
Table 61. BECTON DICKINSON Sexually Transmitted Diseases (STD) Testing Products, Services and Solutions
Table 62. Revenue (US$ Million) in Sexually Transmitted Diseases (STD) Testing Business of BECTON DICKINSON (2018-2023)
Table 63. BECTON DICKINSON Recent Developments
Table 64. ORASURE Basic Information List
Table 65. ORASURE Description and Business Overview
Table 66. ORASURE Sexually Transmitted Diseases (STD) Testing Products, Services and Solutions
Table 67. Revenue (US$ Million) in Sexually Transmitted Diseases (STD) Testing Business of ORASURE (2018-2023)
Table 68. ORASURE Recent Developments
Table 69. DANAHER Basic Information List
Table 70. DANAHER Description and Business Overview
Table 71. DANAHER Sexually Transmitted Diseases (STD) Testing Products, Services and Solutions
Table 72. Revenue (US$ Million) in Sexually Transmitted Diseases (STD) Testing Business of DANAHER (2018-2023)
Table 73. DANAHER Recent Developments
Table 74. AFFYMETRIX Basic Information List
Table 75. AFFYMETRIX Description and Business Overview
Table 76. AFFYMETRIX Sexually Transmitted Diseases (STD) Testing Products, Services and Solutions
Table 77. Revenue (US$ Million) in Sexually Transmitted Diseases (STD) Testing Business of AFFYMETRIX (2018-2023)
Table 78. AFFYMETRIX Recent Developments
Table 79. ABBOTT LABORATORIES Basic Information List
Table 80. ABBOTT LABORATORIES Description and Business Overview
Table 81. ABBOTT LABORATORIES Sexually Transmitted Diseases (STD) Testing Products, Services and Solutions
Table 82. Revenue (US$ Million) in Sexually Transmitted Diseases (STD) Testing Business of ABBOTT LABORATORIES (2018-2023)
Table 83. ABBOTT LABORATORIES Recent Developments
Table 84. BIO-RAD LABORATORIES Basic Information List
Table 85. BIO-RAD LABORATORIES Description and Business Overview
Table 86. BIO-RAD LABORATORIES Sexually Transmitted Diseases (STD) Testing Products, Services and Solutions
Table 87. Revenue (US$ Million) in Sexually Transmitted Diseases (STD) Testing Business of BIO-RAD LABORATORIES (2018-2023)
Table 88. BIO-RAD LABORATORIES Recent Developments
Table 89. DIASORIN Basic Information List
Table 90. DIASORIN Description and Business Overview
Table 91. DIASORIN Sexually Transmitted Diseases (STD) Testing Products, Services and Solutions
Table 92. Revenue (US$ Million) in Sexually Transmitted Diseases (STD) Testing Business of DIASORIN (2018-2023)
Table 93. DIASORIN Recent Developments
Table 94. North America Sexually Transmitted Diseases (STD) Testing Market Size by Country (2018-2023) & (US$ Million)
Table 95. North America Sexually Transmitted Diseases (STD) Testing Market Size by Country (2024-2033) & (US$ Million)
Table 96. Europe Sexually Transmitted Diseases (STD) Testing Market Size by Country (2018-2023) & (US$ Million)
Table 97. Europe Sexually Transmitted Diseases (STD) Testing Market Size by Country (2024-2033) & (US$ Million)
Table 98. Asia-Pacific Sexually Transmitted Diseases (STD) Testing Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 99. Asia-Pacific Sexually Transmitted Diseases (STD) Testing Market Size by Region (2018-2023) & (US$ Million)
Table 100. Asia-Pacific Sexually Transmitted Diseases (STD) Testing Market Size by Region (2024-2033) & (US$ Million)
Table 101. Asia-Pacific Sexually Transmitted Diseases (STD) Testing Market Share by Region (2018-2023)
Table 102. Asia-Pacific Sexually Transmitted Diseases (STD) Testing Market Share by Region (2024-2033)
Table 103. Latin America Sexually Transmitted Diseases (STD) Testing Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 104. Latin America Sexually Transmitted Diseases (STD) Testing Market Size by Country (2018-2023) & (US$ Million)
Table 105. Latin America Sexually Transmitted Diseases (STD) Testing Market Size by Country (2024-2033) & (US$ Million)
Table 106. Middle East & Africa Sexually Transmitted Diseases (STD) Testing Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 107. Middle East & Africa Sexually Transmitted Diseases (STD) Testing Market Size by Country (2018-2023) & (US$ Million)
Table 108. Middle East & Africa Sexually Transmitted Diseases (STD) Testing Market Size by Country (2024-2033) & (US$ Million)
Table 109. Sexually Transmitted Diseases (STD) Testing Market Trends
Table 110. Sexually Transmitted Diseases (STD) Testing Market Drivers
Table 111. Sexually Transmitted Diseases (STD) Testing Market Challenges
Table 112. Sexually Transmitted Diseases (STD) Testing Market Restraints
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Sexually Transmitted Diseases (STD) Testing Market Size Year-over-Year 2018-2033 & (US$ Million)
Figure 2. Global Sexually Transmitted Diseases (STD) Testing Market Size (US$ Million), 2018 VS 2022 VS 2033
Figure 3. Global Sexually Transmitted Diseases (STD) Testing Market Share by Regions: 2022 VS 2033
Figure 4. Global Sexually Transmitted Diseases (STD) Testing Forecasted Market Size Share by Region (2024-2033)
Figure 5. North America Sexually Transmitted Diseases (STD) Testing Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 6. Europe Sexually Transmitted Diseases (STD) Testing Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 7. Asia-Pacific Sexually Transmitted Diseases (STD) Testing Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 8. Latin America Sexually Transmitted Diseases (STD) Testing Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 9. Middle East & Africa Sexually Transmitted Diseases (STD) Testing Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 10. Product Picture of Chlamydia
Figure 11. Global Chlamydia Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 12. Product Picture of Syphilis
Figure 13. Global Syphilis Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 14. Product Picture of Gonorrhea
Figure 15. Global Gonorrhea Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 16. Product Picture of Herpes Simplex Virus
Figure 17. Global Herpes Simplex Virus Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 18. Product Picture of Human Papilloma Virus
Figure 19. Global Human Papilloma Virus Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 20. Product Picture of Human Immunodeficiency Virus
Figure 21. Global Human Immunodeficiency Virus Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 22. Product Picture of Others
Figure 23. Global Others Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 24. Global Sexually Transmitted Diseases (STD) Testing Market Size Share by Type: 2022 & 2033
Figure 25. North America Sexually Transmitted Diseases (STD) Testing Revenue Market Share by Type (2018-2033)
Figure 26. Europe Sexually Transmitted Diseases (STD) Testing Revenue Market Share by Type (2018-2033)
Figure 27. Asia-Pacific Sexually Transmitted Diseases (STD) Testing Revenue Market Share by Type (2018-2033)
Figure 28. Latin America Sexually Transmitted Diseases (STD) Testing Revenue Market Share by Type (2018-2033)
Figure 29. Middle East and Africa Sexually Transmitted Diseases (STD) Testing Revenue Market Share by Type (2018-2033)
Figure 30. Laboratory Testing Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 31. Point of Care (POC) Testing Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 32. Global Sexually Transmitted Diseases (STD) Testing Market Size Share by Application: 2022 & 2033
Figure 33. North America Sexually Transmitted Diseases (STD) Testing Revenue Market Share by Application (2018-2033)
Figure 34. Europe Sexually Transmitted Diseases (STD) Testing Revenue Market Share by Application (2018-2033)
Figure 35. Asia-Pacific Sexually Transmitted Diseases (STD) Testing Revenue Market Share by Application (2018-2033)
Figure 36. Latin America Sexually Transmitted Diseases (STD) Testing Revenue Market Share by Application (2018-2033)
Figure 37. Middle East and Africa Sexually Transmitted Diseases (STD) Testing Revenue Market Share by Application (2018-2033)
Figure 38. Sexually Transmitted Diseases (STD) Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 39. Global Top 5 and Top 10 Players Sexually Transmitted Diseases (STD) Testing Market Share in 2022
Figure 40. North America Sexually Transmitted Diseases (STD) Testing Market Share by Country (2018-2033)
Figure 41. U.S. Sexually Transmitted Diseases (STD) Testing Market Size (2018-2033) & (US$ Million)
Figure 42. Canada Sexually Transmitted Diseases (STD) Testing Market Size (2018-2033) & (US$ Million)
Figure 43. Germany Sexually Transmitted Diseases (STD) Testing Market Size (2018-2033) & (US$ Million)
Figure 44. France Sexually Transmitted Diseases (STD) Testing Market Size (2018-2033) & (US$ Million)
Figure 45. U.K. Sexually Transmitted Diseases (STD) Testing Market Size (2018-2033) & (US$ Million)
Figure 46. Italy Sexually Transmitted Diseases (STD) Testing Market Size (2018-2033) & (US$ Million)
Figure 47. Russia Sexually Transmitted Diseases (STD) Testing Market Size (2018-2033) & (US$ Million)
Figure 48. Nordic Countries Sexually Transmitted Diseases (STD) Testing Market Size (2018-2033) & (US$ Million)
Figure 49. Asia-Pacific Sexually Transmitted Diseases (STD) Testing Market Share by Region (2018-2033)
Figure 50. China Sexually Transmitted Diseases (STD) Testing Market Size (2018-2033) & (US$ Million)
Figure 51. Japan Sexually Transmitted Diseases (STD) Testing Market Size (2018-2033) & (US$ Million)
Figure 52. South Korea Sexually Transmitted Diseases (STD) Testing Market Size (2018-2033) & (US$ Million)
Figure 53. Southeast Asia Sexually Transmitted Diseases (STD) Testing Market Size (2018-2033) & (US$ Million)
Figure 54. India Sexually Transmitted Diseases (STD) Testing Market Size (2018-2033) & (US$ Million)
Figure 55. Australia Sexually Transmitted Diseases (STD) Testing Market Size (2018-2033) & (US$ Million)
Figure 56. Latin America Sexually Transmitted Diseases (STD) Testing Market Share by Country (2018-2033)
Figure 57. Mexico Sexually Transmitted Diseases (STD) Testing Market Size (2018-2033) & (US$ Million)
Figure 58. Brazil Sexually Transmitted Diseases (STD) Testing Market Size (2018-2033) & (US$ Million)
Figure 59. Middle East & Africa Sexually Transmitted Diseases (STD) Testing Market Share by Country (2018-2033)
Figure 60. Turkey Sexually Transmitted Diseases (STD) Testing Market Size (2018-2033) & (US$ Million)
Figure 61. Saudi Arabia Sexually Transmitted Diseases (STD) Testing Market Size (2018-2033) & (US$ Million)
Figure 62. UAE Sexually Transmitted Diseases (STD) Testing Market Size (2018-2033) & (US$ Million)
Figure 63. Bottom-up and Top-down Approaches for This Report

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries